BioHarvest Sciences Inc. Common Stock (BHST) Stock Price

BHSTStock
$2.0246.88%52W
Market Cap$45.79M
P/E
PEG Ratio
Div yield
Beta-0.34

BHST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.65%
Price vs S&P 500 (4W)-0.97%
VGM Score56.74

BHST Earnings Surprise History

Q2 25-0.24est. -0.11
Q3 25-0.14est. -0.12
Q4 25-0.10est. -0.10
Q1 26-0.11est. -0.12
Q2 26-0.17est. -0.12

BHST Analyst Recommendations

Jan 2025
Feb 2025
Mar 2025
Apr 2025
4.14
4.13
4.13
4.13

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
BHSTBioHarvest Sciences Inc. Common Stock
CAD$2.02
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences owns patented technology for large-scale plant cell cultivation that produces active plant ingredients directly, without growing whole plants. The company operates across two segments: nutraceuticals such as dietary supplements and botanical-derived Active Pharmaceutical Ingredients for therapeutic use. This platform approach offers potential advantages in production scalability and supply chain efficiency.